ALTERYX INC [AYX], ALIBABA GROUP [BABA], BAIDU INC [BIDU], CATERPILLAR INC [CAT], CELLULAR BIOMEDICINE GROUP [CBMG], CAREDX INC [CDNA], CODEXIS INC [CDXS] Price Technical Analysis Elliott Wave and Trading Levels  - tradinglounge

TRADING EDUCATION - ANALYSIS - TRADES  - 20 DAY TRIAL
TradingLounge's  20 DAY TRIAL  https://tradinglounge.com/ 


ALTERYX INC [AYX] (NYSE)
Alteryx is an American computer software company based in Irvine, California, with a development center in Broomfield, Colorado. The company's products are used for data science and analytics. The software is designed to make advanced analytics accessible to any data worker.

ALIBABA GROUP [BABA] (NYSE - ADR)
Alibaba Group Holding Limited, also known as Alibaba Group and as Alibaba.com, is a Chinese multinational technology company specializing in e-commerce, retail, Internet, and technology

BAIDU INC [BIDU] (NASDAQ - ADR)
Baidu, Inc. is a Chinese multinational technology company specializing in Internet-related services and products and artificial intelligence, headquartered in Beijing's Haidian District. It is one of the largest AI and internet companies in the world.

CATERPILLAR INC [CAT] (NYSE)
Caterpillar Inc. is an American Fortune 100 corporation which designs, develops, engineers, manufactures, markets, and sells machinery, engines, financial products, and insurance to customers via a worldwide dealer network. It is the world's largest construction equipment manufacturer.

CELLULAR BIOMEDICINE [CBMG] (NASDAQ)
Cellular Biomedicine Group, Inc. operates as a biopharmaceutical company. The Company develops cell therapies for the treatment of cancer and degenerative diseases. Cellular Biomedicine Group serves patients in China and the United States

CAREDX INC [CDNA] (NASDAQ)
CareDx CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.

CODEXIS [CDXS] (NASDAQ)
Codexis, Inc. is a leading protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food

Risk Disclaimer

As with any day trading or investing opportunity there is a risk of losing part or all of your capital that Trading Lounge expresses opinions on.

Note: Historical trading results are no guarantee of future returns.

Some investments are inherently more risky than others.  At worst, you could lose your entire investment and more, so seek financial advice from your financial adviser.

TradingLounge™ uses a range of technical analysis tools, such as Elliott Wave, software and basic fundamental analysis as well as economic forecasts aimed at minimising the potential for loss.  

The advice we provide through our TradingLounge™ websites and our TradingLounge™ Membership and social media platforms has been prepared without taking into account your particular objectives, financial situation or needs. Reliance on such advice, information or data is at your own risk.

The decision to trade and the method of trading is for you alone to decide, tradinglounge takes no responsibility whatsoever for your trading profits or losses.

This information is of a general nature only, so you should, before acting upon any of the information or advice provided by us, 
consider the appropriateness of the advice in light of your own objectives, financial situation or needs. 
Therefore, you should consult your financial advisor or accountant to determine whether trading in Indices ETFs Stocks shares Forex  CFDs Options Spread Betting
derivatives of any kind / products are appropriate for you in light of your financial trading circumstances.

As with any investment opportunity there is a risk of making losses on investments that Trading Lounge expresses opinions on.

Historical results are no guarantee of future returns. Some investments are inherently riskier than others. At worst, you could lose your entire investment. TradingLounge™ uses a range of technical analysis tools, software and basic fundamental analysis as well as economic forecasts aimed at minimizing the potential for loss.

The advice we provide through our TradingLounge™ websites and our TradingLounge™ Membership has been prepared without considering your objectives, financial situation or needs. Reliance on such advice, information or data is at your own risk. The decision to trade and the method of trading is for you alone to decide. This information is of a general nature only, so you should, before acting upon any of the information or advice provided by us, consider the appropriateness of the advice considering your own objectives, financial situation or needs. Therefore, you should consult your financial advisor or accountant to determine whether trading in securities and derivatives products is appropriate for you considering your financial circumstances.

Recommended Content


Recommended Content

Editors’ Picks

EUR/USD holds above 1.0650 after US data

EUR/USD holds above 1.0650 after US data

EUR/USD retreats from session highs but manages to hold above 1.0650 in the early American session. Upbeat macroeconomic data releases from the US helps the US Dollar find a foothold and limits the pair's upside.

EUR/USD News

GBP/USD retreats toward 1.2450 on modest USD rebound

GBP/USD retreats toward 1.2450 on modest USD rebound

GBP/USD edges lower in the second half of the day and trades at around 1.2450. Better-than-expected Jobless Claims and Philadelphia Fed Manufacturing Index data from the US provides a support to the USD and forces the pair to stay on the back foot.

GBP/USD News

Gold clings to strong daily gains above $2,380

Gold clings to strong daily gains above $2,380

Gold trades in positive territory above $2,380 on Thursday. Although the benchmark 10-year US Treasury bond yield holds steady following upbeat US data, XAU/USD continues to stretch higher on growing fears over a deepening conflict in the Middle East.

Gold News

Ripple faces significant correction as former SEC litigator says lawsuit could make it to Supreme Court

Ripple faces significant correction as former SEC litigator says lawsuit could make it to Supreme Court

Ripple (XRP) price hovers below the key $0.50 level on Thursday after failing at another attempt to break and close above the resistance for the fourth day in a row. 

Read more

Have we seen the extent of the Fed rate repricing?

Have we seen the extent of the Fed rate repricing?

Markets have been mostly consolidating recent moves into Thursday. We’ve seen some profit taking on Dollar longs and renewed demand for US equities into the dip. Whether or not this holds up is a completely different story.

Read more

Majors

Cryptocurrencies

Signatures